CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-29 | Bennett Jean Director | Grant or award | +9,807 | 28,861 | ||
| 2026-05-29 | Bennett Jean Director | Grant or award · Stock Options (Right to Buy) | +46,600 | 46,600 | ||
| 2025-05-30 | Bennett Jean Director | Grant or award | +7,768 | 19,054 | ||
| 2025-05-30 | Bennett Jean Director | Grant or award · Stock Options (Right to Buy) | +39,815 | 39,815 | ||
| 2024-05-31 | Bennett Jean Director | Grant or award | +4,790 | 11,286 | ||
| 2024-05-31 | Bennett Jean Director | Grant or award · Stock Options (Right to Buy) | +24,454 | 24,454 | ||
| 2023-06-02 | Bennett Jean Director | Grant or award | +3,486 | 6,496 | ||
| 2023-06-02 | Bennett Jean Director | Grant or award · Stock Options (Right to Buy) | +17,892 | 17,892 | ||
| 2022-06-03 | Bennett Jean Director | Grant or award | +3,010 | 3,010 | ||
| 2022-06-03 | Bennett Jean Director | Grant or award · Stock Option (Right to Buy) | +15,324 | 15,324 | ||
| 2021-09-03 | Bennett Jean Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 |
Page 1 of 1 · 11 trades